{
  "docId": "019de50e-d292-716f-9ce2-d72fb83a57c0",
  "docSlug": "bede1f03edbb16951b81551a4f6eebab",
  "documentTitle": "Theranos | Investor Conference Presentation Deck | 88 slides",
  "authorId": "theranos",
  "authorName": "Theranos",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2016-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 73,
  "pageCount": 88,
  "prevPage": 72,
  "nextPage": 74,
  "slideType": "problem_statement",
  "function": "diagnose_problem",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "This slide outlines technical mitigation strategies for blood sample collection issues.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de50e-d292-716f-9ce2-d72fb83a57c0/73",
  "deckHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0",
  "deckJsonHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0.json",
  "deckAnchorHref": "/decks/019de50e-d292-716f-9ce2-d72fb83a57c0#slide-73",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "disclaimer",
      "text": "This technology has not been cleared or approved by the FDA and is not for sale in the United States.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb5981f4-3cd8-4807-995d-f4769878b042",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.9,
        "x": 0.05,
        "y": 0.235
      },
      "kind": "table",
      "text": "Challenges: Hemolysis, Clotting, Altered cell morphology. Theranos Design Considerations: Capillary tubes, Shape/diameter, Anti-coagulant coating, Anti-coagulant concentration, Rapid mixing, Fill volume indicators, Optimized anti-coagulant concentration.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42706ad8-9d23-4ed3-be73-713c6f2d2b0b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "Sample Collection Device Design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e0c74e5-33a8-4449-8485-3d97525a983c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "8a5dc3e8-a4ed-4784-931b-32f35bc243dd",
      "evidence": "table/data: Challenges: Hemolysis, Clotting, Altered cell morphology. Theranos Design Considerations: Capillary tubes, Shape/diameter, Anti-coagulant coating, Anti-coagulant concentration, Rapid mixing, Fill volume indic",
      "confidence": 0.9
    }
  ],
  "frameworks": [
    {
      "name": "diagnostic-test",
      "slug": null,
      "matchId": "67687aa9-caf8-4f73-8727-9631bd6d3d94",
      "evidence": "Maps specific technical problems to design solutions.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 78,
      "from": 68,
      "beatId": "6bbf63ac-3933-426f-9fc3-95c3a9d80e7e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Results",
      "beatSlug": null,
      "evidence": "The document presents the results and data",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}